PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro

논문상세정보
' PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 생물학
  • circadianclockgene
  • colorectal cancer
  • mir-103
  • period3
  • vitro
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
649 0

0.0%

' PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro' 의 참고문헌

  • p53 in health and disease
    Vousden, K. H. Nat. Rev. Mol. Cell Biol 8 : 275 ~ 283 [2007]
  • microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3
    Yu, D. Oncol. Lett 3 : 1221 ~ 1226 [2012]
  • miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis
    Gaziel-Sovran, A. Cancer Cell 20 : 104 ~ 118 [2011]
  • miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells
    Liu, M. Int. J. Cancer 128 : 1269 ~ 1279 [2011]
  • miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4
    Chen, H. Y. Cancer Res 72 : 3631 ~ 3641 [2012]
  • The role of circadian regulation in cancer
    Gery, S. Cold. Spring. Harb. Symp. Quant. Biol 72 : 459 ~ 464 [2007]
  • Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study
    Zhu, Y. Cancer Res 69 : 9315 ~ 9322 [2009]
  • Reduced expression of PER3 is associated with incidence and development of colon cancer
    Wang, X. Ann. Surg. Oncol 19 : 3081 ~ 3088 [2012]
  • PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells
    Sato, F. Eur. J. Cancer 47 : 1747 ~ 1758 [2011]
  • Molecular components of the Mammalian circadian clock
    Buhr, E. D Handb. Exp. Pharmacol 217 : 3 ~ 27 [2013]
  • MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
    Asangani, I. A. Oncogene 27 : 2128 ~ 2136 [2008]
  • MicroRNA- 335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1
    Xu, Y. Oncogene 31 : 1398 ~ 1407 [2012]
  • MicroRNA signatures in human cancers
    Calin, G. A. Nat. Rev. Cancer 6 : 857 ~ 866 [2006]
  • Metabolism and cancer: the circadian clock connection
    Sahar, S. Nat. Rev. Cancer 9 : 886 ~ 896 [2009]
  • Induction of genetic instability by gain-offunction p53 cancer mutants
    Xu, Y. Oncogene 27 : 3501 ~ 3507 [2008]
  • Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study
    Weber, D. G. PLoS One 7 : e30221 ~ [2012]
  • Cyclin-dependent kinase pathways as targets for cancer treatment
    Shapiro, G. I. J. Clin. Oncol 24 : 1770 ~ 1783 [2006]
  • Control mechanism of the circadian clock for timing of cell division in vivo
    Matsuo, T. Science 302 : 255 ~ 259 [2003]
  • Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients
    Mazzoccoli, G. Chronobiol. Int 28 : 841 ~ 851 [2011]
  • Cell death: critical control points
    Danial, N. N. Cell 116 : 205 ~ 219 [2004]
  • Bim, Bad, and Bax: a deadly combination in epileptic seizures
    Niquet, J. J. Clin. Invest 113 : 960 ~ 962 [2004]
  • A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2
    Annibali D PLoS One 7 : e40269 ~ [2012]